13G Filing: Opaleye Management and Inotek Pharmaceuticals Corp (ITEK)

Page 3 of 7 – SEC Filing

 

CUSIP
No.
45780V102  

 

  NAMES
OF REPORTING PERSONS
1

I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

 

Opaleye,
L.P.

   CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
   
  (a)
[  ]
2 (b)
[  ]
  SEC
USE ONLY
   
3  
  CITIZENSHIP
OR PLACE OF ORGANIZATION
   
4 Delaware
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY EACH
REPORTING
PERSON WITH
  5.  

SOLE
VOTING POWER

 

0

  6.  

SHARED
VOTING POWER

 

1,555,000

  7.  

SOLE
DISPOSITIVE POWER

 

0

  8.  

SHARED
DISPOSITIVE POWER

 

1,555,000

  AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
9 1,555,000
  CHECK
IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
10 [  ]
  PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
11 5.76%
(Please see Item 4 below)
  TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS)
   
12 PN

 

Follow Rocket Pharmaceuticals Inc. (NASDAQ:RCKT)